Understanding the Tip:
The role of amber containers in photostability:
Photostability studies are designed to evaluate how exposure to light affects the chemical and physical stability of pharmaceutical products. However, samples not intended for direct light exposure—such as dark controls—must be completely shielded from stray light throughout the study. Using dark amber containers ensures that only the exposed samples reflect degradation from controlled lighting conditions, while dark controls remain unaffected. This contrast is essential for accurate interpretation of photostability outcomes.
Risks of using improper containers during light studies:
If control samples are stored in clear or semi-transparent containers:
- They may be inadvertently exposed to light from the environment or chamber reflections
- Baseline degradation could occur, invalidating comparative results
- Regulators may question whether adequate shielding procedures were followed
These errors can mislead formulation decisions or trigger regulatory concerns during dossier review or inspections.
Regulatory and Technical Context:
ICH and WHO guidance on photostability testing standards:
ICH Q1B and WHO TRS 1010 provide detailed guidance on how photostability testing should be conducted. Both require inclusion of “dark controls” to distinguish light-induced degradation from other stability risks. The use of opaque or amber containers for these controls ensures they are not exposed during the test. This approach reflects Good Laboratory Practice (GLP) and strengthens
Audit readiness and CTD expectations:
In CTD Module 3.2.P.8.3, photostability outcomes must clearly show the difference between light-exposed and protected samples. Auditors may ask to see evidence of how samples were shielded from unintended exposure. Photographic documentation, container specifications, and packaging procedures should be available for inspection. Using standardized amber containers removes ambiguity and demonstrates a consistent control strategy.
Best Practices and Implementation:
Select appropriate amber containers for dark controls:
Choose containers that provide:
- Complete blockage of UV and visible light
- Chemical compatibility with the product
- Tight seals to prevent atmospheric influence
Amber glass vials, HDPE bottles with amber tint, and light-protective sleeves are acceptable. Avoid repurposing containers unless validated for light transmission properties.
Establish SOPs and handling protocols for protection:
Include the following in your photostability SOPs:
- Definition and labeling of “light” vs. “dark” control groups
- Instructions to keep dark samples inside amber containers or wrap them in aluminum foil
- Separate placement of controls in designated trays or boxes within the chamber
Train lab personnel on minimizing exposure during setup, storage, and retrieval. Implement visual markers or tags for “DO NOT EXPOSE” to reinforce awareness.
Document container use and validate shielding effectiveness:
Maintain records of container lot numbers, material composition, and prior usage. Where necessary, conduct validation studies to confirm the UV-blocking efficiency of the chosen containers. For regulatory submissions, include:
- Photographs of test setup
- Details of light control measures
- Summary of any observed degradation in dark controls
This documentation supports a defensible claim that all observed changes were attributable to light exposure—not procedural oversights.
Using dark amber containers in photostability testing is a simple but critical practice that upholds data reliability, regulatory trust, and scientific accuracy across all pharmaceutical dosage forms.